Home NDC 43742-2040-1 Vir Combination
Product NDC 43742-2040
Requested package NDC 43742-2040-1
11-digit product format 437422040
Labeler code 43742
Product ID 43742-2040_730cbe69-d67d-4041-bb71-46cc2829bcda
Type HUMAN OTC DRUG
Nonproprietary name Influenzinum (2021-2022), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode
Dosage form LIQUID
Route ORAL
Labeler Deseret Biologicals, Inc.
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 2022-02-02
Marketing end 2027-08-23
Substance INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 5; HEPATITIS B VIRUS; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN; HUMAN HERPESVIRUS 4
Active strength 12; 12; 12; 12; 15; 15; 15; 18; 33; 12; 12; 16 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL
Pharmacologic classes Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Live Human Adenovirus Type 7 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]
NDC exclude flag No
Current FDA listing Yes Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Vir Combination Active Ingredients# Ingredient, Strength table Ingredient Strength INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 12 [hp_X]/mL INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) 12 [hp_X]/mL INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED) 12 [hp_X]/mL INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED) 12 [hp_X]/mL HUMAN HERPESVIRUS 1 15 [hp_X]/mL HUMAN HERPESVIRUS 2 15 [hp_X]/mL HUMAN HERPESVIRUS 6 15 [hp_X]/mL HUMAN HERPESVIRUS 5 18 [hp_X]/mL HEPATITIS B VIRUS 33 [hp_X]/mL HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN 12 [hp_C]/mL HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN 12 [hp_C]/mL HUMAN HERPESVIRUS 4 16 [hp_C]/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 12 matching rows.
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 43742-2040-1 Vir Combination 30 mL in 1 BOTTLE, DROPPER LIQUID 30 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 43742-2040 VIR COMBINATION (INFLUENZINUM (2021-2022), HERPES SIMPLEX 1 NOSODE, HERPES SIMPLEX 2 NOSODE, HUMAN HERPESVIRUS 6A, HUMAN HERPESVIRUS 6B, CYTOMEGALOVIRUS NOSODE, HEPATITIS B NOSODE, ADENOVIREN NOSODE, EPSTEIN-BARR VIRUS NOSODE) LIQUID [DESERET BIOLOGICALS, INC.] 3 Current NDC, Legacy NDC, 1 package rows 20221209_b5275aba-df1f-4ee9-adcd-41021cf3df58.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Vir Combination INFLUENZINUM (2021-2022), HERPES SIMPLEX 1 NOSODE, HERPES SIMPLEX 2 NOSODE, HUMAN HERPESVIRUS 6A, HUMAN HERPESVIRUS 6B, CYTOMEGALOVIRUS NOSODE, HEPATITIS B NOSODE, ADENOVIREN NOSODE, EPSTEIN-BARR VIRUS NOSODE Deseret Biologicals, Inc. b5275aba-df1f-4ee9-adcd-41021cf3df58 2022-12-07 Warnings Exact identifier ndc (package): 43742-2040-1 ndc (product): 43742-2040 ndc11 (package): 43742204001
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 43742-2040-1 43742204001 30 mL in 1 BOTTLE, DROPPER (43742-2040-1) 30 ml 2022-02-02 2027-08-23 No No Current